Furthermore, TCGA database showed that a poorer prognosis was observed in HCC patients with high levels of TMED9 and TMED3 in tumors compared to patients with low levels of TMED9 and TMED3 in tumors (Fig. 6d). The gene discussed is TMED9; the disease is hepatocellular carcinoma.